Therapeutic effect of betaine on diabetic nephropathy in db/db mice

Chen Jigang,Pang Qi,Zeng Wei,Guo Yanhong,Mu Jiao,Nie Ling,Yuan Fahuan,Feng Bing
DOI: https://doi.org/10.16016/j.1000-5404.2012.11.015
2012-01-01
Abstract:Objective To study the effect of betaine on diabetic nephropathy(DN) in mice.Methods Thirty-six db/db mice were randomly divided into DN group(n=18) and betaine treatment group(n=18),with 18 db/m mice served as a normal control group(NC group).At the end of 4,8 and 12 weeks,GRP78 expression level in the renal tissue was measured by real-time quantitative fluorescence PCR and Western blotting,urine monocyte chemoattractant protein-1(MCP-1) concentration was assayed by ELISA,and dynamic renal pathology,blood glucose(BG),serum creatinine(SCr),blood urea nitrogen(BUN),24-hour urinary albumin excretion rate(UAER) were tested with routine pathological and biochemical methods.Results The BG,BUN,24-h UAER and MCP-1 levels were significantly higher in DN group than in NC group(P<0.05),which became significantly lower after betaine treatment.However,betaine had no effect on Scr.The glomerular basement membrane was thicker,the number of mesangial cells was greater,and more mesangial matrix was accumulated in DN group than in NC group at 12 weeks(P<0.05),which were significantly alleviated after betaine treatment.The GRP78 mRNA and protein expression levels were significantly higher in DN group than in NC group(P<0.05),which became significantly lower after betaine treatment(P<0.05).Conclusion Betaine can exert its effect on DN in db/db mice by alleviating endoplasmic reticulum stress(ERS) and related inflammatory reactions.
What problem does this paper attempt to address?